Selvita Past Earnings Performance
Past criteria checks 5/6
Selvita has been growing earnings at an average annual rate of 39.2%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 29.9% per year. Selvita's return on equity is 15%, and it has net margins of 14.4%.
Key information
39.2%
Earnings growth rate
20.5%
EPS growth rate
| Life Sciences Industry Growth | 26.0% |
| Revenue growth rate | 29.9% |
| Return on equity | 15.0% |
| Net Margin | 14.4% |
| Next Earnings Update | 21 Nov 2024 |
Recent past performance updates
Recent updates
Is Selvita (WSE:SLV) Using Too Much Debt?
Sep 26
It's Unlikely That The CEO Of Selvita S.A. (WSE:SLV) Will See A Huge Pay Rise This Year
Jun 14Earnings Report: Selvita S.A. Missed Revenue Estimates By 7.1%
May 26Selvita's (WSE:SLV) Solid Earnings May Rest On Weak Foundations
Apr 03Selvita S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Apr 01Selvita S.A. (WSE:SLV) Analysts Just Cut Their EPS Forecasts Substantially
Oct 07We Think Selvita (WSE:SLV) Can Stay On Top Of Its Debt
Sep 28Here's Why Selvita (WSE:SLV) Has Caught The Eye Of Investors
Jun 02Selvita (WSE:SLV) Seems To Use Debt Quite Sensibly
Jun 09These 4 Measures Indicate That Selvita (WSE:SLV) Is Using Debt Reasonably Well
Feb 23If You Like EPS Growth Then Check Out Selvita (WSE:SLV) Before It's Too Late
Mar 31Here's What Selvita S.A.'s (WSE:SLV) Shareholder Ownership Structure Looks Like
Feb 25Here's Why We Don't Think Selvita's (WSE:SLV) Statutory Earnings Reflect Its Underlying Earnings Potential
Jan 22
Is Now The Time To Put Selvita (WSE:SLV) On Your Watchlist?
Dec 25Did You Miss Selvita's (WSE:SLV) Impressive 113% Share Price Gain?
Dec 02Revenue & Expenses Breakdown
How Selvita makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 329 | 47 | 198 | 0 |
| 31 Mar 24 | 337 | 65 | 198 | 0 |
| 31 Dec 23 | 352 | 70 | 206 | 0 |
| 30 Sep 23 | 358 | 20 | 205 | 0 |
| 30 Jun 23 | 369 | 31 | 209 | 0 |
| 31 Mar 23 | 372 | 24 | 215 | 0 |
| 31 Dec 22 | 365 | 26 | 212 | 0 |
| 30 Sep 22 | 364 | 20 | 219 | 0 |
| 30 Jun 22 | 351 | 11 | 220 | 0 |
| 31 Mar 22 | 329 | 12 | 211 | 0 |
| 31 Dec 21 | 316 | 15 | 198 | 0 |
| 30 Sep 21 | 260 | 12 | 162 | 0 |
| 30 Jun 21 | 216 | 18 | 131 | 0 |
| 31 Mar 21 | 181 | 22 | 105 | 0 |
| 31 Dec 20 | 142 | 18 | 85 | 0 |
| 30 Sep 20 | 158 | 21 | 92 | 0 |
| 30 Jun 20 | 99 | 15 | 58 | 0 |
| 31 Mar 20 | 63 | 9 | 36 | 0 |
| 31 Dec 19 | 54 | 7 | 30 | 0 |
| 30 Sep 19 | 22 | 2 | 14 | 0 |
| 31 Mar 19 | 81 | 10 | 49 | 0 |
| 31 Dec 18 | 77 | 10 | 47 | 0 |
| 31 Dec 17 | 56 | 4 | 36 | 0 |
Quality Earnings: SLV has high quality earnings.
Growing Profit Margin: SLV's current net profit margins (14.4%) are higher than last year (8.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SLV's earnings have grown significantly by 39.2% per year over the past 5 years.
Accelerating Growth: SLV's earnings growth over the past year (54.1%) exceeds its 5-year average (39.2% per year).
Earnings vs Industry: SLV earnings growth over the past year (54.1%) exceeded the Life Sciences industry -9.9%.
Return on Equity
High ROE: SLV's Return on Equity (15%) is considered low.